Person looking into a microscope

Department of Brain Health News

The UNLV Department of Brain Health will advance research, education, and practice to benefit brain health and the care and treatment of people with brain disorders across the life span. Our faculty specialize in several areas that range from basic and clinical research in neurodegenerative disease, neuropsychology, and occupational therapy.

Current Brain Health News

detail shot of lab equipment
Campus News | June 21, 2022

UNLV expert Dr. Jeffrey Cummings explains how a new lab expands UNLV's neuroscience research capabilities.

a teacher and student in a classroom
Campus News | March 7, 2022

A collection of news stories highlighting the experts and events at UNLV.

brain circuitry outlined in blue lights
Research | February 17, 2022

Joint Center for Neurodegeneration and Translational Neuroscience earns continuation funding to support regional research, infrastructure, and career development.

U.N.L.V. signage with Fall leaves in the background
Business and Community | December 28, 2021

A yearlong collection of headlines featuring innovative ideas, discoveries, and partnerships to move Southern Nevada forward.

people doing research
Research | December 27, 2021

UNLV researchers made international headlines this year with their discoveries. Here's a roundup of some of our top stories of 2021.

D73794_046 Family Brunch 2021.JPG
Campus News | November 4, 2021

A collection of news stories featuring stargazing and change at UNLV.

Brain Health In The News

Voice of America
September 28, 2022

Drugmakers Biogen and Eisai say their experimental drug lecanemab slowed the progress of Alzheimer’s disease in a large human study the companies did.

Reuters
September 28, 2022

An experimental Alzheimer's drug made by Eisai Co Ltd (4523.T) and Biogen (BIIB.O) slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs.

U.S. News & World Report
September 28, 2022

An experimental Alzheimer's drug made by Eisai Co Ltd and Biogen slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs.

Health Europa
May 31, 2022

NervGen is developing a novel drug candidate that could revolutionise treatment for conditions associated with central nervous system damage, including Alzheimer’s disease.

Health Day
May 27, 2022

The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer's disease research, two new studies show.

U.S. News & World Report
May 27, 2022

The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer's disease research, two new studies show.

Brain Health Experts

An international expert on neurodegenerative diseases and brain health.
A renowned expert on Alzheimer's Disease and other neurodegenerative disorders. 
An expert in behavioral neuroscience with concentrations in Alzheimer's disease and schizophrenia.
A national expert in mindfulness-based occupational therapy and mental health.

Recent Brain Health Accomplishments

August 31, 2022
Doctoral student Rachel DeWald (Psychology, Brain Health) received the Spring 2022 cover artwork award for the Spectra Undergraduate Research Journal. The Office of Undergraduate Research solicits student submissions for the award to have a student-designed cover for each spring and fall issue. The competitive award intends to foster student…
May 10, 2022
Dr. Jeffrey Cummings (Brain Health) released the fifth annual Alzheimer’s Disease Drug Development Pipeline: 2022 publication. The paper reviews the current pipeline of drugs in clinical trials for the treatment of Alzheimer's disease (AD). It examines an updated view of clinical trials, new drugs, and offers a future outlook on drug development…
October 14, 2021
Kristine Bragg, Gwen Marchand, Jonathan Hilpert (all Educational Psychology and Higher Education), and Jeffrey Cummings (Brain Health) recently published the manuscript, "Using Bibliometrics to Evaluate Outcomes and Influence of Translational Biomedical Research Centers" in the Journal of Clinical and Translational Science.
September 8, 2021
Ryan Wirt, Lauren Crew Andrew Ortiz, and Emmanuel Flores (all Neuroscience), Jefferson Kinney (Brain Health), and James Hyman (Psychology) published an article in Communications Biology entitled "Altered theta rhythm and hippocampal-cortical interactions underlie working memory deficits in a hyperglycemia risk factor model of Alzheimer’s disease…
August 13, 2021
Samantha John (DBrain Health) and colleagues published an investigation of two novel smartphone applications that were developed to assess cognitive functioning, "Examination of the reliability and feasibility of two smartphone applications to assess executive functioning in racially diverse older adults." The manuscript, published in the journal …
July 29, 2021
Dr. Jeff Cummings (Brain Health) published "Trial of Pimavanserin in Dementia-Related Psychosis" in the New England Journal of Medicine.